glp-1 small molecule agonist agonists Full-length human GLP-1 receptor structure

Abstract Sulfonamides, which are drugs commonly prescribed in hospital and outpatient settings, have historically been associated with a high incidence of hypersensitivity reactions

Addressing metabolic activation as an integral component of drug design

Biomarker analyses from a placebo-controlled phase II study evaluating erlotinib +/ onartuzumab in advanced non-small cell lung cancer: MET expression levels are predictive of patient benefit

Separate vials allow independent dose control, which matters for TB-500-heavy injury protocols, but they require more injections per session and three reconstitutions

Monitor for any new side effects that emerge at the higher dose